trial
as of 2026-07-01Role of Anti-Inflammatory Agents in Patients With Schizophrenia
NCTId NCT00929955
at a glance
Phase 1 · Completed
Enrollment 36 (actual)
Sponsored by Pakistan Institute of Living and Learning
Primary completion 2009-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 1
Status
Completed
Enrollment
36 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2009-06
Primary completion
2009-09
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
Pakistan Institute of Living and LearningLead Sponsor
Karwan e Hayat, Karachi, PakistanCollaborator
Dow University of Health SciencesCollaborator
Investigators
1
Prof Imran B Chaudhry, MDPrincipal Investigator
Sites
2 total
Karachi, PakistanKarachi, Pakistan
Facts & assertions
4 sourced
Enrollment
36
Phase
PHASE1
Primary Completion Date
2009-09
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
collaborator
indication
investigator